July 31, 2024
A ruling out of a Delaware federal court on Wednesday prevented a major Japanese pharmaceutical company from using patent law to block an Indian rival's efforts to market a generic version of a blockbuster kidney disease treatment.
December 14, 2023
As the year winds down, a Delaware federal judge is set to oversee a trial over a major Japanese pharmaceutical company's claims that an Indian rival's efforts to market a generic version of a blockbuster kidney disease treatment infringe its patents. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.